Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA neratinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Topotecan CCLE pan-cancer AAC 0.015 0.7
mRNA Nilotinib CCLE pan-cancer AAC -0.017 0.7
mRNA Imatinib CTRPv2 pan-cancer AAC 0.012 0.7
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.017 0.7
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV